Lp(a): When to Measure it and What to Do About it

Collaborative CME and Research Network

M. O'Donoghue

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

Management of AF patients with ACS

Lankenau

P. Kowey, D. Ice

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

Coronary Calcium Testing: Principles and Clinical Application

Right Care Initiative

A. Taylor

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Hypertension 2025: New Guidelines and Resistant Hypertension

University of Louisville

K. Ferdinand

Treatment of Chronic Kidney Disease and Heart Failure Circa 2024

WCIRDC

K. R. Tuttle

TCT 2024 Insights: Antiplatelet Therapy and All-Cause Mortality Afte…

TCT 2024 Insights

M. Zimarino

Intravenous ADP Antagonist: Use in High-Risk PCI and ACS

San Diego Cardiovascular Interventions Symposium 2024

E. Mahmud

Beyond 10-Year Risk: New Paradigms for Long-Term Risk Estimation Wit…

Heart in Diabetes (HiD)

S. Khan

Time to Retire Aspirin?

Top Ten Topics in Clinical Cardiology 2021

R. Mehran

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

I Ordered an Lp(a) Level – Now What?

Collaborative CME and Research Network

M. O'Donoghue